Evidence map›Paper›PMID 33431675›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

The amphibian antimicrobial peptide uperin 3.5 is a cross-α/cross-β chameleon functional amyloid.

Nir Salinas, Einav Tayeb-Fligelman, Massimo D Sammito, Daniel Bloch, Raz Jelinek, Dror Noy, Isabel Usón, Meytal Landau

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A functional amyloid scaffold shapes insect egg coats.bioRxiv : the preprint server for biology · 2026
    Article
  5. Designability of α-Helical Protein Filaments.Sub-cellular biochemistry · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Science advances · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Mechanisms and pathology of protein misfolding and aggregation.Nature reviews. Molecular cell biology · 2023
    Review
  16. Article
  17. Fragment-BasedACS bio & med chem Au · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Nir SalinasDepartment of Biology, Technion - Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0000-0002-3511-2243
Einav Tayeb-FligelmanDepartment of Biology, Technion - Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0000-0001-9318-5400
Massimo D SammitoCrystallographic Methods, Institute of Molecular Biology of Barcelona-Spanish Research Council, 08028 Barcelona, Spain.
Daniel BlochDepartment of Chemistry, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Raz JelinekDepartment of Chemistry, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Dror NoyMigal-Galilee Research Institute, Kiryat Shmona 1101602, Israel.ORCID 0000-0001-7200-7453
Isabel UsónCrystallographic Methods, Institute of Molecular Biology of Barcelona-Spanish Research Council, 08028 Barcelona, Spain.ORCID 0000-0003-2504-1696
Meytal LandauDepartment of Biology, Technion - Israel Institute of Technology, Haifa 3200003, Israel; mlandau@technion.ac.il.ORCID 0000-0002-1743-3430
Technion – Israel Institute of Technology · ILBen-Gurion University of the Negev · ILInstitució Catalana de Recerca i Estudis Avançats · ESInstitut de Biologia Molecular de Barcelona · ESMigal - Galilee Technology Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial activity is being increasingly linked to amyloid fibril formation, suggesting physiological roles for some human amyloids, which have historically been viewed as strictly pathological agents. This work reports on formation of functional cross-α amyloid fibrils of the amphibian antimicrobial peptide uperin 3.5 at atomic resolution, an architecture initially discovered in the bacterial PSMα3 cytotoxin. The fibrils of uperin 3.5 and PSMα3 comprised antiparallel and parallel helical sheets, respectively, recapitulating properties of β-sheets. Uperin 3.5 demonstrated chameleon properties of a secondary structure switch, forming mostly cross-β fibrils in the absence of lipids. Uperin 3.5 helical fibril formation was largely induced by, and formed on, bacterial cells or membrane mimetics, and led to membrane damage and cell death. These findings suggest a regulation mechanism, which includes storage of inactive peptides as well as environmentally induced activation of uperin 3.5, via chameleon cross-α/β amyloid fibrils.

Indexed as

Amino Acid SequenceAmyloid beta-PeptidesAnimalsAntimicrobial Cationic PeptidesBacterial ProteinsBinding SitesCrystallography, X-RayCytotoxinsKineticsLizardsMicrobial Sensitivity TestsModels, MolecularProtein BindingProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandProtein Interaction Domains and MotifsAmyloid beta-PeptidesAntimicrobial Cationic PeptidesBacterial ProteinsCytotoxinsuperin 3.5amyloidantimicrobial peptidescross-alphafunctional fibril

Identifiers

PMID33431675
PMCPMC7826344
OpenAlexW3120995461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.